Our group is focused on antimicrobial drug discovery and aims to develop new tools and means to confront the global challenge posed by increasing antimicrobial resistance.
We are part of the Drug Research Program and affiliated with the Division of Pharmaceutical Biosciences at the Faculty of Pharmacy, University of Helsinki. Our facilities are located in Biocenter 2E on Viikki Campus.
We are also hosting the Bioactivity Screening Unit, which provides researchers access to screening instrumentation as well as consultation in matters such as compound libraries, screening assay development and quality control relevant for screening campaigns. This unit belongs to the Drug Discovery and Chemical Biology network, and is a HiLIFE infrastructure facility.